Skip to main content

Remote Job Finders (RJF)

Lilly wheels and deals, Moderna gets boost on hantavirus scare, ASCO excitement builds

Eli Lilly continues to spend its GLP-1 landfall with four new deals in the past week, including three in the vaccine space; the obesity leader also touted surgery-like results for its next-gen weight loss drug; Moderna’s stock climbs on the hantavirus “fear trade”; and in oncology, all eyes are on Revolution at ASCO this week.

Germany can produce biotech winners. Europe must back them better.

Strong science and early support are not enough on their own. Europe needs more capital depth, cross-border investor backing and a lighter policy framework to keep companies scaling at home, according to two venture capitalists.
Scroll to top